Lantheus Holdings Cost of Goods Sold 2013-2024 | LNTH

Lantheus Holdings annual/quarterly cost of goods sold history and growth rate from 2013 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
  • Lantheus Holdings cost of goods sold for the quarter ending December 31, 2024 was $0.143B, a 14.85% increase year-over-year.
  • Lantheus Holdings cost of goods sold for the twelve months ending December 31, 2024 was $0.546B, a 7.03% decline year-over-year.
  • Lantheus Holdings annual cost of goods sold for 2024 was $0.546B, a 7.03% decline from 2023.
  • Lantheus Holdings annual cost of goods sold for 2023 was $0.587B, a 66.09% increase from 2022.
  • Lantheus Holdings annual cost of goods sold for 2022 was $0.353B, a 48.77% increase from 2021.
Lantheus Holdings Annual Cost of Goods Sold
(Millions of US $)
2024 $546
2023 $587
2022 $353
2021 $238
2020 $201
2019 $173
2018 $168
2017 $169
2016 $164
2015 $158
2014 $176
2013 $206
2012 $213
Lantheus Holdings Quarterly Cost of Goods Sold
(Millions of US $)
2024-12-31 $143
2024-09-30 $137
2024-06-30 $138
2024-03-31 $128
2023-12-31 $124
2023-09-30 $120
2023-06-30 $119
2023-03-31 $224
2022-12-31 $96
2022-09-30 $92
2022-06-30 $86
2022-03-31 $80
2021-12-31 $72
2021-09-30 $59
2021-06-30 $55
2021-03-31 $51
2020-12-31 $56
2020-09-30 $52
2020-06-30 $40
2020-03-31 $53
2019-12-31 $45
2019-09-30 $44
2019-06-30 $41
2019-03-31 $42
2018-12-31 $42
2018-09-30 $44
2018-06-30 $42
2018-03-31 $40
2017-12-31 $43
2017-09-30 $41
2017-06-30 $43
2017-03-31 $42
2016-12-31 $40
2016-09-30 $39
2016-06-30 $42
2016-03-31 $43
2015-12-31 $38
2015-09-30 $40
2015-06-30 $41
2015-03-31 $39
2014-12-31
2014-09-30 $44
2014-06-30 $45
2013-12-31
2012-12-31
Sector Industry Market Cap Revenue
Medical MED PRODUCTS $7.447B $1.534B
Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) US $231.085B 27.79
Boston Scientific (BSX) US $155.199B 38.86
Stryker (SYK) US $144.362B 30.19
EssilorLuxottica (ESLOY) FR $132.860B 0.00
Medtronic (MDT) IE $108.824B 15.89
Lonza Group Ag (LZAGY) CH $52.624B 0.00
Haleon (HLN) GB $48.277B 27.44
ResMed (RMD) US $35.183B 26.43
GE HealthCare Technologies (GEHC) US $32.295B 15.33
Agilent Technologies (A) US $30.971B 20.46
Terumo (TRUMY) JP $29.019B 0.00
Koninklijke Philips (PHG) NL $24.053B 17.17
Zimmer Biomet Holdings (ZBH) US $20.255B 12.80
Insulet (PODD) US $18.084B 77.18
Baxter (BAX) US $15.752B 11.77
Smith & Nephew SNATS (SNN) GB $12.535B 0.00
Sunny Optical Technology (SNPTF) CN $9.032B 0.00
Demant (WILYY) DK $7.970B 0.00
Bio-Rad Laboratories (BIO) US $6.620B 22.38
Prestige Consumer Healthcare (PBH) US $4.171B 19.90
Perrigo (PRGO) IE $3.497B 10.01
ICU Medical (ICUI) US $3.486B 29.69
Shandong Weigao Medical Polymer (SHWGF) CN $3.459B 0.00
Haemonetics (HAE) US $3.208B 15.09
Envista Holdings (NVST) US $2.879B 23.93
GN Store Nord (GNNDY) DK $2.068B 17.13
QuidelOrtho (QDEL) US $1.964B 16.45
LeMaitre Vascular (LMAT) US $1.778B 39.75
AtriCure (ATRC) US $1.486B 0.00
Green Thumb Industries (GTBIF) US $1.374B 21.63
Neogen (NEOG) US $1.248B 15.97
Kestra Medical Technologies (KMTS) US $1.220B 0.00
BioLife Solutions (BLFS) US $1.200B 0.00
AdaptHealth (AHCO) US $1.184B 11.40
InMode (INMD) IL $1.013B 9.28
Phibro Animal Health (PAHC) US $0.789B 12.10
Evolus (EOLS) US $0.779B 0.00
Curaleaf Holdings (CURLF) CA $0.636B 0.00
CeriBell (CBLL) US $0.588B 0.00
Owens & Minor (OMI) US $0.580B 4.94
Valneva SE (VALN) FR $0.549B 0.00
Capricor Therapeutics (CAPR) US $0.542B 0.00
Maravai LifeSciences Holdings (MRVI) US $0.526B 0.00
Tilray Brands (TLRY) CA $0.458B 0.00
Cresco Labs (CRLBF) US $0.442B 0.00
Omeros (OMER) US $0.418B 0.00
Surmodics (SRDX) US $0.395B 0.00
SNDL (SNDL) CA $0.365B 0.00
VAREX IMAGING (VREX) US $0.359B 15.55
SEMPERIT AG HLD (SEIGY) AT $0.317B 0.00
Verano Holdings (VRNOF) US $0.296B 0.00
Sanara MedTech (SMTI) US $0.292B 0.00
Viemed Healthcare (VMD) US $0.291B 26.32
Aurora Cannabis (ACB) CA $0.272B 48.40
Sanuwave Health (SNWV) US $0.264B 0.00
ZimVie (ZIMV) US $0.261B 15.60
Cerus (CERS) US $0.258B 0.00
Canopy Growth (CGC) CA $0.245B 0.00
Quanterix (QTRX) US $0.233B 0.00
OraSure Technologies (OSUR) US $0.231B 0.00
High Tide (HITI) CA $0.194B 0.00
Biote (BTMD) US $0.190B 4.35
Utah Medical Products (UTMD) US $0.173B 13.93
Brainsway (BWAY) IL $0.170B 53.06
TriSalus Life Sciences (TLSI) US $0.165B 0.00
FitLife Brands (FTLF) US $0.148B 18.22
Organigram Global (OGI) CA $0.145B 0.00
Jin Medical (ZJYL) CN $0.119B 0.00
TerrAscend (TSNDF) CA $0.116B 0.00
MacroGenics (MGNX) US $0.110B 0.00
Exagen (XGN) US $0.108B 0.00
Agape ATP (ATPC) $0.099B 0.00
Oramed Pharmaceuticals (ORMP) US $0.095B 0.00
Quipt Home Medical (QIPT) US $0.094B 0.00
Fonar (FONR) US $0.076B 10.70
Jushi Holdings (JUSHF) US $0.076B 0.00
Veru (VERU) US $0.075B 0.00
InterCure (INCR) IL $0.073B 0.00
Zynex (ZYXI) US $0.070B 0.00
United Health Products (UEEC) US $0.064B 0.00
Cytosorbents (CTSO) US $0.059B 0.00
ImmuCell (ICCC) US $0.048B 0.00
Apyx Medical (APYX) US $0.047B 0.00
Modular Medical (MODD) US $0.042B 0.00
Rockwell Medical (RMTI) US $0.042B 61.50
United-Guardian (UG) US $0.037B 11.28
Safety Shot (SHOT) US $0.036B 0.00
Nephros (NEPH) US $0.020B 0.00
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) IE $0.015B 0.00
Cellectar Biosciences (CLRB) US $0.012B 0.00
Flora Growth (FLGC) US $0.012B 0.00
Allurion Technologies (ALUR) US $0.011B 0.00
NeuroMetrix (NURO) US $0.009B 0.00
Meihua Medical Technologies (MHUA) CN $0.007B 0.00
Innovative Eyewear (LUCY) US $0.005B 0.00
GlucoTrack (GCTK) US $0.004B 0.00
Senestech (SNES) US $0.004B 0.00
IM Cannabis (IMCC) CA $0.004B 0.00
Akanda (AKAN) GB $0.002B 0.00
Sharps Technology (STSS) US $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) US $0.000B 0.00